Mechanistically, although PRMT5 does not directly regulate PRC2 enzymatic activity, its methylation of histone H3 interferes with subsequent PRC2-mediated trimethylation, highlighting a complex and tumor-specific interplay between arginine and lysine methylation. The gene discussed is PRMT5; the disease is neoplasm.